Log In
Log in

by Pierian, on June 15, 2022

ST. LOUIS, June 15, 2022 --Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Pierian’s leading-edge clinical genomics workflow, and precision medicine services with Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer.

Read Story
Content not found